BIO KEY INTERNATIONAL INC — Form 8-K
Filed October 2, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Bio-Key agreed to exchange a portion of a $1,130,000 promissory note (dated September 30, 2025) issued to Streeterville Capital, LLC for unspecified shares of common stock. The Exchange Agreement, dated September 29, 2026, partitions an unspecified amount from the original note and converts it to equity with Rule 144 free-trading provisions. Critical terms—the partitioned note amount and share count—are left blank in the filed document, preventing precise valuation of the dilution.
Why this rating
Debt-to-equity conversion on a $4.9M market-cap company is material; blank terms create uncertainty. Dilution likely substantial relative to company size, but unquantifiable specifics in filing reduce precision of impact assessment.
Price action (we called it negative)
before filing · preread $2.06 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.